Anti-OLM2B/ OLFML2B functional antibody

Anti-OLM2B/ OLFML2B functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to OLFML2B/OLFML2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0387-Ab-1/ GM-Tg-hg-SE0387-Ab-2Anti-Human OLFML2B monoclonal antibodyHuman
GM-Tg-rg-SE0387-Ab-1/ GM-Tg-rg-SE0387-Ab-2Anti-Rat OLFML2B monoclonal antibodyRat
GM-Tg-mg-SE0387-Ab-1/ GM-Tg-mg-SE0387-Ab-2Anti-Mouse OLFML2B monoclonal antibodyMouse
GM-Tg-cynog-SE0387-Ab-1/ GM-Tg-cynog-SE0387-Ab-2Anti-Cynomolgus/ Rhesus macaque OLFML2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0387-Ab-1/ GM-Tg-felg-SE0387-Ab-2Anti-Feline OLFML2B monoclonal antibodyFeline
GM-Tg-cang-SE0387-Ab-1/ GM-Tg-cang-SE0387-Ab-2Anti-Canine OLFML2B monoclonal antibodyCanine
GM-Tg-bovg-SE0387-Ab-1/ GM-Tg-bovg-SE0387-Ab-2Anti-Bovine OLFML2B monoclonal antibodyBovine
GM-Tg-equg-SE0387-Ab-1/ GM-Tg-equg-SE0387-Ab-2Anti-Equine OLFML2B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0387-Ab-1/ GM-Tg-hg-SE0387-Ab-2; GM-Tg-rg-SE0387-Ab-1/ GM-Tg-rg-SE0387-Ab-2;
GM-Tg-mg-SE0387-Ab-1/ GM-Tg-mg-SE0387-Ab-2; GM-Tg-cynog-SE0387-Ab-1/ GM-Tg-cynog-SE0387-Ab-2;
GM-Tg-felg-SE0387-Ab-1/ GM-Tg-felg-SE0387-Ab-2; GM-Tg-cang-SE0387-Ab-1/ GM-Tg-cang-SE0387-Ab-2;
GM-Tg-bovg-SE0387-Ab-1/ GM-Tg-bovg-SE0387-Ab-2; GM-Tg-equg-SE0387-Ab-1/ GM-Tg-equg-SE0387-Ab-2
Products NameAnti-OLFML2B monoclonal antibody
Formatmab
Target NameOLFML2B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OLFML2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0387-Ag-1Recombinant multi-species OLM2B/ OLFML2B protein


    Target information

    Target IDGM-SE0387
    Target NameOLFML2B
    Gene ID25903,320078,304960,720062,488661,101087039,513053,100050561
    Gene Symbol and Synonyms1110018N05Rik,4832415H08Rik,OLFML2B
    Uniprot AccessionQ68BL8,A6QLD2
    Uniprot Entry NameOLM2B_HUMAN,OLM2B_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseOvary Cancer
    Gene EnsemblENSG00000162745
    Target ClassificationN/A

    The target: OLFML2B, gene name: OLFML2B, also named as . This gene encodes an olfactomedin domain-containing protein. Most olfactomedin domain-containing proteins are secreted glycoproteins. [provided by RefSeq, Dec 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.